Citius Oncology holds annual shareholder meeting
CTOR•Citius Oncology held its annual stockholders meeting on September 29, 2026; shareholders elected three Class II directors and ratified Wolf & Company, P.C. as its independent auditor for fiscal 2026.
1. Meeting results
Stockholders elected Eugene Holuka, Robert Smith and Carol Webb as Class II directors. They also ratified Wolf & Company, P.C. as the independent registered public accounting firm for the fiscal year ended September 30, 2026.
